This year’s annual Kidney Week will begin with a special opening plenary on countering the threat of future pandemics. What will we learn from this session?
At this year’s annual Kidney Week, hosted by the American Society of Nephrology, experts from around the world are gathering together to explore how the field of nephrology has changed, specifically amid the ongoing COVID-19 pandemic. And in partnership with the National Academy of Medicine, Kidney Week 2022 will kick off with a special opening plenary on countering the threat of future pandemics.
In this session, titled “Joint ASN-National Academy of Medicine Opening Plenary: ASN President's Address, Expert Panel "Preventing the Next Pandemic,” experts from around the world will discuss the following:
- Developments in nephrology propelling major improvements in patient care and delivery of care
- Barriers to the widespread delivery of treatment advancements and of kidney disease awareness
- Strategies we can implement to help prevent the next pandemic
The session will feature three presentations: the ASN President’s Address, hosted by Dr. Susan E. Quaggin; the “Preventing the Next Pandemic” keynote, hosted by Dr. Peter J. Hotez; and the “Preventing the Next Pandemic” panel, featuring Drs. Carlos del Rio, Timothy G. Evans, Peter J. Hotez, Jennifer B. Nuzzo, and Reed V. Tuckson.
One of the speakers, Dr. Hotez, is the Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology and Microbiology at Baylor College of Medicine in Houston, Texas. He’s also the Co-director of the Texas Children's Hospital Center for Vaccine Development, where he leads a team working to develop vaccines impacting millions of patients worldwide, including hookworm infection, schistosomiasis, leishmaniasis, Chagas disease, and COVID-19. He’s also the author of “Preventing the Next Pandemic: Vaccine Diplomacy in a Time of Anti-science.”
The session also features insights from Dr. del Rio, a distinguished Professor of Medicine in the Division of Infectious Diseases at the Emory University School of Medicine in Atlanta, Georgia; Co-director of the Emory Center for AIDS Research; and Co-principal investigator of the Emory−Centers for Disease Control and Prevention HIV Clinical Trials Unit.
Specifically, in regard to COVID-19, Dr. del Rio has conducted research, developed policies, and written scientific publications on this topic. His research focuses on early diagnosis, access to care, compliance with antiretrovirals, and prevention of HIV infection.